stella
beta
PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer — Stella
Recruiting
Back to Metastatic Lung Non-Small Cell Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
View full record on ClinicalTrials.gov